Table 2.

Treatment Outcomes by Study Group^a

	No./Total (%)		Difference (95% CI), %
	Ciprofloxacin	Cefpodoxime
Primary outcomes
Overall clinical cureb	139/150 (93)	123/150 (82)	11 (3 to 18)
Overall clinical curec	124/150 (83)	106/150 (71)	12 (3 to 21)
Per-protocol analysis	124/135 (92)	106/133 (80)	12 (4 to 20)
Secondary outcomes
Early clinical cured	140/150 (93)	132/150 (88)	5 (−1 to 12)
Early microbiological cured	123/128 (96)	104/129 (81)	15 (8 to 23)

^aSee text for definitions.

^bIntent-to-treat analysis, imputing values for patients without follow-up visits as having clinical cure.

^cIntent-to-treat analysis, imputing values for patients without follow-up visits as not having responded to treatment.

^dAt first follow-up visit.